XML 21 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2019
Revenue:      
Total revenue $ 105,136 $ 94,864 $ 100,077
Operating costs and expenses:      
Type of Cost, Good or Service [Extensible List] Product Sales [Member] Product Sales [Member] Product Sales [Member]
Product costs $ 17,177 $ 15,317 $ 13,639
Research and development 46,734 50,188 52,885
Selling, general and administrative 30,677 28,392 23,950
Acquired intangible asset amortization 2,793 2,218 2,405
Acquisition transaction, integration and other costs 1,049    
Contingent consideration expense (gain) 3   (161)
Acquired in-process research and development     890
Total operating costs and expenses 98,433 96,115 93,608
Operating income (loss) 6,703 (1,251) 6,469
Other (expense) income:      
Investment income, net 123 656 1,097
Interest expense (310) (133) (152)
Foreign exchange (loss) gain (170) (248) 134
(Loss) gain on strategic investments and other   (478) 10
Other (expense) income (357) (203) 1,089
Income (loss) before income taxes 6,346 (1,454) 7,558
Income tax (provision) benefit (2,109) 2,577 34
Net income $ 4,237 $ 1,123 $ 7,592
Basic net income per share $ 0.31 $ 0.08 $ 0.57
Diluted net income per share $ 0.30 $ 0.08 $ 0.55
Weighted average number of shares outstanding:      
Basic 13,765 13,552 13,389
Diluted 13,989 13,812 13,779
Product Sales [Member]      
Revenue:      
Total revenue $ 46,478 $ 44,317 $ 40,219
Royalties and License Fees [Member]      
Revenue:      
Total revenue 47,056 40,634 48,458
Research, Development and Other [Member]      
Revenue:      
Total revenue $ 11,602 $ 9,913 $ 11,400